Effective minocycline treatment enhances clinical Klebsiella pneumoniae infections: Investigation of biofilm resistance mutations and antimicrobial efficacy in pediatric infections
Microbial Pathogenesis · 2025
DOI: 10.1016/j.micpath.2025.107703 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbial Pathogenesis, 2025. Verfasst von Zhaowen Wang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric, Dongying People's Hospital, Dongying, 257000, China. Electronic address: Zhaowenmicrobio@outlook.com. Hauptthemen laut MEDLINE: Klebsiella pneumoniae, Biofilms, Anti-Bacterial Agents, Klebsiella Infections. Die Arbeit nennt 52 Literaturangaben.
Abstract (Originalsprache)
The extensive use of antibacterial agent has led to a steady decline in the clinical exposure of Klebsiella pneumoniae to carbapenems (CPM), creating considerable obstacles for infection control and clinical disinfection. K. pneumoniae utilizes the development of dense biofilms and overexpression of efflux pumps to circumvent the detrimental properties of CPM. Minocycline (MCL) is a promising antibacterial agent that reduces proton motive forces and increases membrane permeability. This study demonstrated the synergistic antibacterial effect of MCL and CPM, which significantly lowered the MIC of CPM-resistant K. pneumoniae. Importantly, using crystal violet and live/dead staining, we found that MCL markedly improved the anti-biofilm efficacy of CPM. Studies assessing reactive oxygen species, alkaline phosphatase leakage, membrane permeability, and RT-PCR indicated that the combination of MCL and CPM induced oxidative stress, enhanced the permeability of K. pneumoniae membrane, and suppressed the overexpression of the efflux pump genes oqxA and oqxB. Additionally, we performed surface disinfection trials on medicinal tools to replicate clinical settings, revealing that MCL and CPM significantly decreased the bacterial burden by 3 log10 CFU/mL. Furthermore, findings from the resistance mutation frequency assays demonstrated that the combinational therapy (MCL + CPM) diminished the emergence of the K. pneumoniae population. Overall, MCL can function as an ancillary agent, augmenting the biofilm efficacy of CPM and attenuating the emergence of resistance mutation, thus prolonging the efficacy of CPM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric, Dongying People's Hospital, Dongying, 257000, China. Electronic address: Zhaowenmicrobio@outlook.com.
- Department of Pediatric, Dongying People's Hospital, Dongying, 257000, China.
Zitieren
APA
Wang, Z., & Yuan, L. (2025). Effective minocycline treatment enhances clinical Klebsiella pneumoniae infections: Investigation of biofilm resistance mutations and antimicrobial efficacy in pediatric infections. Microbial Pathogenesis. https://doi.org/10.1016/j.micpath.2025.107703
Vancouver
Wang Z, Yuan L. Effective minocycline treatment enhances clinical Klebsiella pneumoniae infections: Investigation of biofilm resistance mutations and antimicrobial efficacy in pediatric infections. Microbial Pathogenesis. 2025. doi:10.1016/j.micpath.2025.107703
BibTeX
@article{Wang2025,
author = {Wang, Zhaowen and Yuan, Lizhen},
title = {Effective minocycline treatment enhances clinical Klebsiella pneumoniae infections: Investigation of biofilm resistance mutations and antimicrobial efficacy in pediatric infections},
journal = {Microbial Pathogenesis},
year = {2025},
doi = {10.1016/j.micpath.2025.107703}
}
EUVIMED